Docetaxel and Diethylstilbestrol (DES)

Phase 2

Sanofi (SNY)

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

9 competitors in Prostate Cancer

CADLaglatimagene besadenovec

Phase 3

CADLAglatimagene besadenovec + valacyclovir

BTAIBXCL701 plus Pembrolizumab

Phase 2

View Full Landscape

Drug Information

Target Indication

Prostate Cancer

Clinical Trial

NCT00136526

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Source: FDA Orange Book

Drug Science

Mechanism of action & safety profile

Developer

SNY

Sanofi

Pharmaceutical Preparations•Europe•NASDAQ

Related Pipeline

SotagliflozinPhase 3

Type 2 Diabetes Mellitus

lunsekimigPhase 3

Chronic Rhinosinusitis With Nasal Polyps

Ombrabulin (AVE8062)Phase 3

Ovarian Cancer Recurrent

LMTPhase 3

Atherosclerotic Cardiovascular Disease

hydroxychloroquine (Z0188)Phase 3

Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus

View full pipeline

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts